MacroGenics
MGNX
#9151
Rank
S$0.14 B
Marketcap
S$2.33
Share price
-5.18%
Change (1 day)
-43.29%
Change (1 year)

Market capitalization of MacroGenics (MGNX)

Market cap: S$0.14 Billion

As of February 2026 MacroGenics has a market cap of S$0.14 Billion. This makes MacroGenics the world's 9151th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of MacroGenics from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026S$0.14 B12.62%
2025S$0.13 B-52.55%
2024S$0.27 B-65.03%
2023S$0.78 B42.51%
2022S$0.55 B-58.43%
2021S$1.33 B-21.79%
2020S$1.70 B

End of Day market cap according to different sources

On Jan 31st, 2026 the market cap of MacroGenics was reported to be:

S$0.14 Billion
by Nasdaq info icon info icon
S$0.14 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
S$191.23 B 129,760.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$1.182 T 803,057.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$234.18 B 158,927.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$224.05 B 152,049.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$350.37 B 237,826.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$142.56 B 96,708.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
S$1.09 B 645.79%๐Ÿ‡บ๐Ÿ‡ธ USA